NCT Number: NCT00482638
Study of Safety, Tolerability and Efficacy of MK0493 in Obese Patients (0493-008)(COMPLETED)
To assess the effect of MK0493 on body weight, blood pressure, mood, and appetite.
Looking for future studies?
Notify MeKey information
Conditions
Age range
21 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 2
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patient is between 21 and 65 years
- Patient is able to read and understand and complete study questionnaires
- Patient is not pregnant or breast-feeding and does not plan to become pregnant for the duration of the study and post-study follow-up period
Exclusion criteria
- Patient has a history of significant psychiatric disorder (such as major depression, bipolar disorder, bulimia, or anorexia nervosa
- Patient is HIV positive as determined by medical history
- Patient has undergone surgical treatment for obesity
- Patient plans to consume more than two 8 ounce glasses of grapefruit juice per day during the study
- Patient participated in another clinical study involving an investigational drug) within 3 months prior to Visit 1
- Patient is currently a heavy consumer of alcohol (>2 drinks per day or >14 drinks per week [1 drink is defined as 2 oz hard alcohol, 5 oz wine, 12 oz beer], or uses (including recreational use) any illicit drugs, or has a history of drug or alcohol abuse
Treatment and study plan
Sponsors and collaborators
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Registry information
Important dates
- Study start
- 2004
- Primary completion
- 2004
- Study completion
- 2004
- First posted
- Jun 5, 2007
- Registry last updated
- Nov 14, 2019
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Effect of Gabapentin on Kidney Function Following Laparoscopic Sleeve Gastrectomy (LSG)
NCT06254183
Acute Kidney Injury, Body Weight
Al Mansurah, Egypt
View Trial DetailsPredicting Weight Gain and Weight Loss Associated With Overeating or Fasting
NCT00687115
Body Weight, Body Weight Changes
Phoenix, Arizona, United States
View Trial DetailsVitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women
NCT00862433
Body Weight, Diabetes
Bethesda, Maryland, United States
View Trial DetailsProbiotics in Obesity Management
NCT06964932
Body Weight, Nutrition Disorders
Luoyang, Henan, China
View Trial Details